Drug-drug interactions induced by immunosuppressants through inhibition of human carboxylesterases
Drug Metabolism and Disposition · 2026-04 · 54 (4) · 100267
DOI: 10.1016/j.dmd.2026.100267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-04. Verfasst von Yuxin Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, North Sichuan Medical College, Nanchong, China. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Carboxylic Ester Hydrolases, Carboxylesterase, Enzyme Inhibitors. Die Arbeit nennt 109 Literaturangaben. Gefördert von: Sichuan Provincial Youth Science and Technology Fund, Bureau of Science and Technology Nanchong City.
Abstract (Originalsprache)
Immunosuppressants are a class of therapeutic agents that attenuate immune responses by modulating pathways involved in immune cell activation, proliferation, and signaling, and are widely used to prevent organ transplant rejection and to treat autoimmune diseases. The present study aimed to evaluate potential drug-drug interactions (DDIs) induced by immunosuppressants through inhibition of human carboxylesterases (CESs). Based on network pharmacology analysis, CESs were identified as potential targets of immunosuppressants and coadministered drugs. In vitro incubation experiments demonstrated that several immunosuppressants strongly inhibited the activities of CES1 and CES2, with inhibition ratios exceeding 70%. Kinetic studies and in vitro-in vivo extrapolation revealed that immunosuppressants might induce DDIs by inhibiting CESs in vivo. Molecular docking and molecular dynamics simulations indicated that hydrogen bonding contributed to the interactions between immunosuppressants and CESs. Furthermore, studies in human liver microsomes and HepG2 cells confirmed that the hydrolysis of aspirin and mycophenolate mofetil was significantly reduced by coadministration. These findings highlight the necessity of careful monitoring for potential DDIs when immunosuppressants are used concomitantly in clinical settings. SIGNIFICANT STATEMENT: This study reveals that immunosuppressants potently inhibit human carboxylesterases (CES1 and CES2), thereby disrupting the metabolic hydrolysis of coadministered drugs and highlighting a critical risk for clinically significant drug-drug interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, North Sichuan Medical College, Nanchong, China.
- Department of Nutrition and Food Hygiene, School of Public Health, North Sichuan Medical College, Nanchong, China; School of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
- Department of Nutrition and Food Hygiene, School of Public Health, North Sichuan Medical College, Nanchong, China. Electronic address: duzuo@nsmc.edu.cn.
Förderung
- Sichuan Provincial Youth Science and Technology Fund
- Bureau of Science and Technology Nanchong City
Zitieren
APA
Yang, Y., Liang, J., Liao, C., Fan, Y., Ma, Y., Long, F., Liu, Z., & Du, Z. (2026). Drug-drug interactions induced by immunosuppressants through inhibition of human carboxylesterases. Drug Metabolism and Disposition, 54(4), 100267. https://doi.org/10.1016/j.dmd.2026.100267
Vancouver
Yang Y, Liang J, Liao C, Fan Y, Ma Y, Long F, et al. Drug-drug interactions induced by immunosuppressants through inhibition of human carboxylesterases. Drug Metabolism and Disposition. 2026;54(4):100267. doi:10.1016/j.dmd.2026.100267
BibTeX
@article{Yang2026,
author = {Yang, Yuxin and Liang, Jiahong and Liao, Chenyuan and Fan, Yuzhi and Ma, Yulin and Long, Fei and Liu, Zhenzhong and Du, Zuo},
title = {Drug-drug interactions induced by immunosuppressants through inhibition of human carboxylesterases},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {4},
pages = {100267},
doi = {10.1016/j.dmd.2026.100267}
}
EUVIMED